Dr. Abigail Suzanne Caudle, MD

Dr. Caudle practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Caudle's NPI, 1265530992, was assigned on September 20, 2006. Dr. Caudle graduated from University of North Carolina School of Medicine in 2000. Dr. Caudle holds Texas license M6069.

Dr. Caudle's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Caudle's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caudle practices. Vendor and product names are available with a free account.

Surgery is Dr. Caudle's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Caudle is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Caudle's licenses on file in 11 states: Texas, Florida, Georgia, Arizona, Louisiana, North Carolina, Oklahoma, Tennessee, Washington, Alabama and Mississippi.

Dmand AI lists mastectomy among the conditions Dr. Caudle treats.

CMS data shows 18 Medicare services from Dr. Caudle across 1 procedure code in 2024, for 22 Medicare patients. Medicare paid $9,216 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 22 Medicare patients who saw Dr. Caudle in 2024. 75% of them have cancer, and 68% have high blood pressure. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Caudle's median patient age at 66, with 97% women.

In 2018, Dr. Caudle wrote 52 Medicare Part D claims. Every claim was for a generic drug. They cover 4 drugs, with $757 in total drug cost. In 2017, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Caudle for performance year 2024, reported as part of a group. Dr. Caudle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of mastectomy by Dr. Caudle, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 113 papers to Dr. Caudle, published from 2006 to 2024. 2015 was the busiest year, with 11. The most frequent topics are Breast Neoplasms, Neoadjuvant Therapy and Axilla. Dr. Caudle has published most often in Ann Surg Oncol. Dr. Caudle's most frequent co-authors are Isabelle Bedrosian, MD, Elizabeth Mittendorf, MD and Kelly K. Hunt, MD.

Dmand AI links Dr. Caudle to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Lobular.

CMS Open Payments shows 31 general payments to Dr. Caudle from 4 drug and device companies from 2017 to 2019. Travel and lodging make up the largest share, 97% of the total. Endomagnetics Ltd paid the most, $23,745.

Dmand AI lists 3 awards for Dr. Caudle, most recently Regional Top Doctor in 2014.

Dr. Caudle graduated from University of North Carolina School of Medicine in 2000. Dr. Caudle is a member of ACS.

Dr. Caudle is in network with 15 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.